LEUSTATIN Side Effects

5753721-2 | Bone Marrow Disorder, Pancytopenia
on May 26, 2008 Male patient from GERMANY , weighting 41.45 lb, was diagnosed with malignant histiocytosis, infection prophylaxis, epilepsy (What is epilepsy?) and was treated with Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow disorder, pancytopenia. Leustatin dosage: . During the same period patient was treated with TRIMETHOPRIM (View Trimethoprim Review and Trimethoprim Label ), AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), SULFAMETHOXAZOL (View Sulfamethoxazol Review and Sulfamethoxazol Label ). Patient was hospitalized.

5746606-9 | Bone Marrow Disorder, Neutrophil Count Decreased, White Blood Cell Count Decreased
Patient was taking Leustatin (View Usage). Patient had the following side effects: bone marrow disorder, neutrophil count decreased, white blood cell count decreased on May 13, 2008 from GERMANY Additional patient health information: Male patient , child 5 years of age, was diagnosed with malignant histiocytosis and. Leustatin dosage: .

5735774-0 | Bone Marrow Disorder, Neutrophil Count Decreased, White Blood Cell Count Decreased
Adverse event was reported on May 05, 2008 by a Male patient taking Leustatin (View Usage) (Dosage: ) was diagnosed with malignant histiocytosis and. Location: GERMANY , child 5 years of age, After Leustatin was administered, patient had the following side effects: bone marrow disorder, neutrophil count decreased, white blood cell count decreased.

5696514-7 | Dermatitis Exfoliative, Inflammation
on Mar 28, 2008 Female patient from FRANCE , weighting 127.9 lb, was diagnosed with hairy cell leukaemia and was treated with Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis exfoliative, inflammation. Leustatin dosage: . During the same period patient was treated with MABTHERA (View Mabthera Review and Mabthera Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), ZOPHREN (View Zophren Review and Zophren Label ), WELLVONE (View Wellvone Review and Wellvone Label ), VALACYCLOVIR (View Valacyclovir Review and Valacyclovir Label ).


5448309-7 | Accidental Overdose, Asthenia, Headache, Inflammation, Insomnia, Pain In Jaw, Pharyngolaryngeal Pain
on Aug 31, 2007 Female patient from FRANCE , weighting 132.3 lb, was diagnosed with systemic mastocytosis and was treated with Leustatin (View Usage). Patient had the following side effects: accidental overdose, asthenia, headache (What is headache?), inflammation, insomnia, pain in jaw, pharyngolaryngeal pain. Leustatin dosage: . During the same period patient was treated with BACTRIM FAIBLE (View Bactrim Faible Review and Bactrim Faible Label ), ZELITREX (View Zelitrex Review and Zelitrex Label ), NEULASTA (View Neulasta Review and Neulasta Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ), CACIT VITAMIN D3 (View Cacit Vitamin D3 Review and Cacit Vitamin D3 Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), INIPOMP (View Inipomp Review and Inipomp Label ), NOXAFIL (View Noxafil Review and Noxafil Label ). Patient was hospitalized.

5428914-4 | Accidental Overdose, Headache, Inflammation, Pain In Jaw, Pharyngolaryngeal Pain
Patient was taking Leustatin (View Usage). After Leustatin was administered, patient had the following side effects: accidental overdose, headache (What is headache?), inflammation, pain in jaw, pharyngolaryngeal pain on Aug 17, 2007 from FRANCE Additional patient health information: Female patient , weighting 132.3 lb, was diagnosed with systemic mastocytosis and. Leustatin dosage: . During the same period patient was treated with BACTRIM FAIBLE (View Bactrim Faible Review and Bactrim Faible Label ), ZELITREX (View Zelitrex Review and Zelitrex Label ), NEULASTA (View Neulasta Review and Neulasta Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ), CACIT VITAMIN D3 (View Cacit Vitamin D3 Review and Cacit Vitamin D3 Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), INIPOMP (View Inipomp Review and Inipomp Label ), NOXAFIL (View Noxafil Review and Noxafil Label ). Patient was hospitalized.

5373707-X | Dizziness
Adverse event was reported on Aug 31, 2006 by a Male patient taking Leustatin (View Usage) (Dosage: 5 Mg/m2, Intravenous) was diagnosed with malignant histiocytosis and. Location: UNITED STATES , child 1 years of age, Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?).

5315441-8 | Confusional State, Paraparesis, Pyrexia
on Apr 23, 2007 Female patient from JAPAN , 72 years of age, was diagnosed with t-cell lymphoma and was treated with Leustatin (View Usage). Patient had the following side effects: confusional state, paraparesis, pyrexia. Leustatin dosage: . During the same period patient was treated with TOPOTECIN (View Topotecin Review and Topotecin Label ).

5287963-X | Confusional State, Paraparesis, Pyrexia
on Mar 29, 2007 Female patient from JAPAN , 72 years of age, was diagnosed with t-cell lymphoma and was treated with Leustatin (View Usage). After Leustatin was administered, patient had the following side effects: confusional state, paraparesis, pyrexia. Leustatin dosage: . During the same period patient was treated with TOPOTECIN (View Topotecin Review and Topotecin Label ).

5286450-2 | Cerebral Haemorrhage
Patient was taking Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage on Mar 26, 2007 from MACEDONIA, THE FORMER YUGOSLAV REPUBLIC OF Additional patient health information: Male patient , weighting 189.6 lb, was diagnosed with hairy cell leukaemia and. Leustatin dosage: . Patient was hospitalized.

5233424-3 | Balance Disorder, Brain Mass, Disturbance In Attention, Grip Strength Decreased, Nerve Injury, Restless Legs Syndrome
Adverse event was reported on Jan 29, 2007 by a Female patient taking Leustatin (View Usage) (Dosage: ) was diagnosed with hairy cell leukaemia, hypertension, gastrooesophageal reflux disease, anxiety (What is anxiety?), asthma (What is asthma?), multiple allergies, hypothyroidism and. Location: UNITED STATES , weighting 140.0 lb, Patient had the following side effects: balance disorder, brain mass, disturbance in attention, grip strength decreased, nerve injury, restless legs syndrome. During the same period patient was treated with MICARDIS (View Micardis Review and Micardis Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), SINGULAIR (View Singulair Review and Singulair Label ), CLARITIN (View Claritin Review and Claritin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

5166586-7 | Nerve Injury
on Nov 24, 2006 Male patient from JAPAN , 65 years of age, was diagnosed with extranodal marginal zone b-cell lymphoma (malt type) and was treated with Leustatin (View Usage). After Leustatin was administered, patient had the following side effects: nerve injury. Leustatin dosage: . During the same period patient was treated with MITOXANTRONE (View Mitoxantrone Review and Mitoxantrone Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ).

5163129-9 | Cerebral Haemorrhage, Neutropenia, Sepsis, Thrombocytopenia
on Nov 29, 2006 Female patient from JAPAN , 79 years of age, was diagnosed with t-cell prolymphocytic leukaemia and was treated with Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, neutropenia, sepsis (What is sepsis?), thrombocytopenia. Leustatin dosage: . During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ), PREDONINE (View Predonine Review and Predonine Label ).

5156202-2 | Nerve Injury
Patient was taking Leustatin (View Usage). Patient had the following side effects: nerve injury on Nov 16, 2006 from JAPAN Additional patient health information: Male patient , 65 years of age, was diagnosed with extranodal marginal zone b-cell lymphoma (malt type) and. Leustatin dosage: . During the same period patient was treated with MITOXANTRONE (View Mitoxantrone Review and Mitoxantrone Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ).

5151100-2 | Anaemia, B-cell Lymphoma, Cystitis Haemorrhagic, Herpes Zoster, Lymphocyte Count Decreased, Nausea, Neutrophil Count Decreased, Platelet Count Decreased, Pneumocystis Jiroveci Pneumonia
Adverse event was reported on Nov 08, 2006 by a Male patient taking Leustatin (View Usage) (Dosage: ) was diagnosed with mantle cell lymphoma, b-cell lymphoma and. Location: JAPAN , 75 years of age, After Leustatin was administered, patient had the following side effects: anaemia, b-cell lymphoma, cystitis haemorrhagic, herpes zoster, lymphocyte count decreased, nausea (What is nausea?), neutrophil count decreased, platelet count decreased, pneumocystis jiroveci pneumonia. During the same period patient was treated with NOVANTRONE (View Novantrone Review and Novantrone Label ). Patient was hospitalized.

5147626-8 | Anaemia, Cystitis Haemorrhagic, Lymphopenia, Myelodysplastic Syndrome, Nausea, Neutropenia, Platelet Count Decreased, Pneumocystis Jiroveci Pneumonia
on Nov 08, 2006 Male patient from JAPAN , 60 years of age, was diagnosed with b-cell lymphoma and was treated with Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, cystitis haemorrhagic, lymphopenia, myelodysplastic syndrome, nausea (What is nausea?), neutropenia, platelet count decreased, pneumocystis jiroveci pneumonia. Leustatin dosage: . During the same period patient was treated with NOVANTRONE (View Novantrone Review and Novantrone Label ). Patient was hospitalized.

5147625-6 | Anaemia, B-cell Lymphoma, Lymphocyte Count Decreased, Myelodysplastic Syndrome, Neutrophil Count Decreased, Platelet Count Decreased
on Nov 08, 2006 Male patient from JAPAN , 72 years of age, was diagnosed with b-cell lymphoma and was treated with Leustatin (View Usage). Patient had the following side effects: anaemia, b-cell lymphoma, lymphocyte count decreased, myelodysplastic syndrome, neutrophil count decreased, platelet count decreased. Leustatin dosage: . During the same period patient was treated with NOVANTRONE (View Novantrone Review and Novantrone Label ).

5147624-4 | Anaemia, Lymphocyte Count Decreased, Mantle Cell Lymphoma, Myelodysplastic Syndrome, Neutrophil Count Decreased, Platelet Count Decreased
Patient was taking Leustatin (View Usage). After Leustatin was administered, patient had the following side effects: anaemia, lymphocyte count decreased, mantle cell lymphoma, myelodysplastic syndrome, neutrophil count decreased, platelet count decreased on Nov 08, 2006 from JAPAN Additional patient health information: Male patient , 73 years of age, was diagnosed with mantle cell lymphoma and. Leustatin dosage: . During the same period patient was treated with NOVANTRONE (View Novantrone Review and Novantrone Label ).

5145825-2 | Haemolytic Anaemia, Hepatotoxicity
Adverse event was reported on Oct 30, 2006 by a Female patient taking Leustatin (View Usage) (Dosage: X 7 Days) was diagnosed with hairy cell leukaemia and. Location: UNITED STATES , 47 years of age, Patient experienced the following unwanted or unexpected effects: haemolytic anaemia, hepatotoxicity. During the same period patient was treated with VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ). Patient was hospitalized.

5141524-1 | Accidental Overdose, Headache, Inflammation, Pain In Jaw, Pharyngolaryngeal Pain
on Oct 24, 2006 Female patient from FRANCE , weighting 132.3 lb, was diagnosed with systemic mastocytosis and was treated with Leustatin (View Usage). Patient had the following side effects: accidental overdose, headache (What is headache?), inflammation, pain in jaw, pharyngolaryngeal pain. Leustatin dosage: . During the same period patient was treated with BACTRIM FAIBLE (View Bactrim Faible Review and Bactrim Faible Label ), ZELITREX (View Zelitrex Review and Zelitrex Label ), NEULASTA (View Neulasta Review and Neulasta Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ), CACIT VITAMIN D3 (View Cacit Vitamin D3 Review and Cacit Vitamin D3 Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), INIPOMP (View Inipomp Review and Inipomp Label ), NOXAFIL (View Noxafil Review and Noxafil Label ). Patient was hospitalized.

5128358-9 | Anaemia, B-cell Lymphoma, Cystitis Haemorrhagic, Herpes Zoster, Lymphocyte Count Decreased, Nausea, Neutrophil Count Decreased, Platelet Count Decreased, Pneumocystis Jiroveci Pneumonia
on Oct 06, 2006 Male patient from JAPAN , 75 years of age, was diagnosed with b-cell lymphoma and was treated with Leustatin (View Usage). After Leustatin was administered, patient had the following side effects: anaemia, b-cell lymphoma, cystitis haemorrhagic, herpes zoster, lymphocyte count decreased, nausea (What is nausea?), neutrophil count decreased, platelet count decreased, pneumocystis jiroveci pneumonia. Leustatin dosage: . During the same period patient was treated with NOVANTRONE (View Novantrone Review and Novantrone Label ). Patient was hospitalized.

5128357-7 | Anaemia, B-cell Lymphoma, Lymphocyte Count Decreased, Myelodysplastic Syndrome, Neutrophil Count Decreased, Platelet Count Decreased
Patient was taking Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, b-cell lymphoma, lymphocyte count decreased, myelodysplastic syndrome, neutrophil count decreased, platelet count decreased on Oct 06, 2006 from JAPAN Additional patient health information: Male patient , 73 years of age, was diagnosed with b-cell lymphoma and. Leustatin dosage: . During the same period patient was treated with NOVANTRONE (View Novantrone Review and Novantrone Label ).

5127452-6 | Anaemia, Cystitis Haemorrhagic, Lymphopenia, Myelodysplastic Syndrome, Nausea, Neutropenia, Platelet Count Decreased, Pneumocystis Jiroveci Pneumonia
Adverse event was reported on Oct 06, 2006 by a Male patient taking Leustatin (View Usage) (Dosage: ) was diagnosed with b-cell lymphoma and. Location: JAPAN , 60 years of age, Patient had the following side effects: anaemia, cystitis haemorrhagic, lymphopenia, myelodysplastic syndrome, nausea (What is nausea?), neutropenia, platelet count decreased, pneumocystis jiroveci pneumonia. During the same period patient was treated with NOVANTRONE (View Novantrone Review and Novantrone Label ). Patient was hospitalized.

5126077-6 | Accidental Overdose
on Oct 04, 2006 Female patient from FRANCE , weighting 132.3 lb, was diagnosed with systemic mastocytosis and was treated with Leustatin (View Usage). After Leustatin was administered, patient had the following side effects: accidental overdose. Leustatin dosage: . During the same period patient was treated with BACTRIM FAIBLE (View Bactrim Faible Review and Bactrim Faible Label ), ZELITREX (View Zelitrex Review and Zelitrex Label ), NEULASTA (View Neulasta Review and Neulasta Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ), CACIT VITAMIN D3 (View Cacit Vitamin D3 Review and Cacit Vitamin D3 Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), INIPOMP (View Inipomp Review and Inipomp Label ), NOXAFIL (View Noxafil Review and Noxafil Label ). Patient was hospitalized.

5099575-1 | Bone Marrow Failure, Pneumonitis Cryptococcal
on Aug 30, 2006 Male patient from JAPAN , 72 years of age, was diagnosed with b-cell lymphoma and was treated with Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, pneumonitis cryptococcal. Leustatin dosage: 0.09 Mg/kg For 7 Days.

5095282-X | Bone Marrow Failure, Pneumonitis Cryptococcal
Patient was taking Leustatin (View Usage). Patient had the following side effects: bone marrow failure, pneumonitis cryptococcal on Aug 24, 2006 from JAPAN Additional patient health information: Male patient , 72 years of age, was diagnosed with b-cell lymphoma and. Leustatin dosage: 0.09 Mg/kg For 7 Days.

5024352-7 | Blood Lactate Dehydrogenase Abnormal, Tumour Haemorrhage
Adverse event was reported on Jun 07, 2006 by a Female patient taking Leustatin (View Usage) (Dosage: ) was diagnosed with b-cell lymphoma and. Location: JAPAN , 41 years of age, After Leustatin was administered, patient had the following side effects: blood lactate dehydrogenase abnormal, tumour haemorrhage.

5020460-5 | Acute Myeloid Leukaemia, Anaemia, Disseminated Intravascular Coagulation, Leukopenia, Mediastinal Haematoma, Pneumonitis, Thrombocytopenia
on May 06, 2005 Female patient from JAPAN , 61 years of age, was diagnosed with hairy cell leukaemia and was treated with Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia, anaemia, disseminated intravascular coagulation, leukopenia, mediastinal haematoma, pneumonitis, thrombocytopenia. Leustatin dosage: .

4965818-5 | Bacterial Sepsis, Gastrointestinal Haemorrhage, Neutropenic Sepsis, Pancytopenia, Renal Failure Acute, Respiratory Failure
on Mar 28, 2006 Male patient from UNITED STATES , weighting 135.0 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Leustatin (View Usage). Patient had the following side effects: bacterial sepsis, gastrointestinal haemorrhage, neutropenic sepsis, pancytopenia, renal failure acute, respiratory failure. Leustatin dosage: . During the same period patient was treated with POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), NEXIUM (View Nexium Review and Nexium Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), LASIX (View Lasix Review and Lasix Label ), METOLAZONE (View Metolazone Review and Metolazone Label ). Patient was hospitalized.

4883043-3 | Renal Tubular Disorder
Patient was taking Leustatin (View Usage). After Leustatin was administered, patient had the following side effects: renal tubular disorder on Jan 06, 2006 from FRANCE Additional patient health information: Male patient , 33 years of age, weighting 242.5 lb, . Leustatin dosage: 5th Cycle. During the same period patient was treated with MINIRIN (View Minirin Review and Minirin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.

4860800-0 | Renal Failure
Adverse event was reported on Dec 15, 2005 by a Male patient taking Leustatin (View Usage) (Dosage: ) . Location: GERMANY , weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: renal failure.

4843625-1 | Renal Failure, Renal Failure Acute
on Nov 21, 2005 Female patient from FRANCE , 30 years of age, was treated with Leustatin (View Usage). Patient had the following side effects: renal failure, renal failure acute. Leustatin dosage: 5th Cycle. During the same period patient was treated with MINIRIN (View Minirin Review and Minirin Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.

4842556-0 | Bone Marrow Failure, Bronchopulmonary Aspergillosis, Sigmoiditis
on Nov 18, 2005 Male patient from FRANCE , weighting 172.0 lb, was treated with Leustatin (View Usage). After Leustatin was administered, patient had the following side effects: bone marrow failure, bronchopulmonary aspergillosis, sigmoiditis. Leustatin dosage: . During the same period patient was treated with SULFAMETHOXAZOLE + TRIMETHOPRIM (View Sulfamethoxazole + Trimethoprim Review and Sulfamethoxazole + Trimethoprim Label ), PRIMPERAN INJ (View Primperan Inj Review and Primperan Inj Label ), ZELITREX (View Zelitrex Review and Zelitrex Label ), G CSF (View G-csf Review and G-csf Label ). Patient was hospitalized.

4823617-9 | Epstein-barr Virus Infection, Hepatic Failure, Non-hodgkin's Lymphoma, Pyrexia, Septic Shock
Patient was taking Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: epstein-barr virus infection, hepatic failure, non-hodgkin's lymphoma, pyrexia, septic shock on Nov 02, 2005 from UNITED STATES Additional patient health information: Female patient , weighting 197.0 lb, . Leustatin dosage: . Patient was hospitalized.

4777089-3 | Diarrhoea, Encephalitis Herpes, Erythema Multiforme, Platelet Count Decreased, Pyrexia, White Blood Cell Count Decreased
Adverse event was reported on Sep 14, 2005 by a Male patient taking Leustatin (View Usage) (Dosage: ) was diagnosed with non-hodgkin's lymphoma, epilepsy (What is epilepsy?) and. Location: JAPAN , 43 years of age, Patient had the following side effects: diarrhoea, encephalitis herpes, erythema multiforme, platelet count decreased, pyrexia, white blood cell count decreased. During the same period patient was treated with VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ).

4771830-1 | Diarrhoea, Encephalitis Herpes, Erythema Multiforme, Platelet Count Decreased, Pyrexia, White Blood Cell Count Decreased
on Sep 08, 2005 Male patient from JAPAN , 43 years of age, was diagnosed with non-hodgkin's lymphoma, epilepsy (What is epilepsy?) and was treated with Leustatin (View Usage). After Leustatin was administered, patient had the following side effects: diarrhoea, encephalitis herpes, erythema multiforme, platelet count decreased, pyrexia, white blood cell count decreased. Leustatin dosage: . During the same period patient was treated with VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ).

4764885-1 | Anuria, Pancytopenia, Renal Failure
on Aug 31, 2005 Female patient from JAPAN , 72 years of age, was treated with Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: anuria, pancytopenia, renal failure. Leustatin dosage: .

4745147-5 | Hepatic Failure, Hepatitis Fulminant
Patient was taking Leustatin (View Usage). Patient had the following side effects: hepatic failure, hepatitis fulminant on Aug 02, 2005 from JAPAN Additional patient health information: Female patient , 60 years of age, . Leustatin dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ).

4731647-0 | Myocarditis, Rhabdomyolysis
Adverse event was reported on Jul 19, 2005 by a Male patient taking Leustatin (View Usage) (Dosage: ) . Location: JAPAN , 44 years of age, After Leustatin was administered, patient had the following side effects: myocarditis, rhabdomyolysis. During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ).

4728551-0 | Hepatitis B
on Jul 20, 2005 Female patient from JAPAN , 56 years of age, was treated with Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis b (What is hepatitis b?). Leustatin dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), MITOXANTRONE (View Mitoxantrone Review and Mitoxantrone Label ), HUMAN BLOOD PREPARATIONS (View Human Blood Preparations Review and Human Blood Preparations Label ). Patient was hospitalized.

4728550-9 | Myocarditis, Rhabdomyolysis
on Jul 19, 2005 Male patient from JAPAN , 44 years of age, was treated with Leustatin (View Usage). Patient had the following side effects: myocarditis, rhabdomyolysis. Leustatin dosage: . During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ).

4720233-4 | Epstein-barr Virus Infection, Pyrexia, Septic Shock
Patient was taking Leustatin (View Usage). After Leustatin was administered, patient had the following side effects: epstein-barr virus infection, pyrexia, septic shock on Jul 14, 2005 from UNITED STATES Additional patient health information: Female patient , 51 years of age, weighting 170.0 lb, . Leustatin dosage: .

4690601-8 | Hepatitis B
Adverse event was reported on Jun 03, 2005 by a Female patient taking Leustatin (View Usage) (Dosage: ) . Location: , 56 years of age, Patient experienced the following unwanted or unexpected effects: hepatitis b (What is hepatitis b?). During the same period patient was treated with HUMAN BLOOD PREPARATIONS (View Human Blood Preparations Review and Human Blood Preparations Label ). Patient was hospitalized.

4664450-0 | Acute Myeloid Leukaemia, Anaemia, Disseminated Intravascular Coagulation, Leukopenia, Mediastinal Haematoma, Pneumonitis, Thrombocytopenia
on May 06, 2005 Female patient from , 61 years of age, was treated with Leustatin (View Usage). Patient had the following side effects: acute myeloid leukaemia, anaemia, disseminated intravascular coagulation, leukopenia, mediastinal haematoma, pneumonitis, thrombocytopenia. Leustatin dosage: .

4661247-2 | Myalgia, Neuropathy Peripheral
on May 27, 2004 Male patient from , 55 years of age, weighting 185.0 lb, was diagnosed with hairy cell leukaemia and was treated with Leustatin (View Usage). After Leustatin was administered, patient had the following side effects: myalgia, neuropathy peripheral. Leustatin dosage: 13.2 Mg, 1 In 1 Day. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

4661244-7 | Febrile Neutropenia
Patient was taking Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia on Jun 17, 2004 from Additional patient health information: Male patient , 31 years of age, was diagnosed with hairy cell leukaemia and. Leustatin dosage: . Patient was hospitalized.

4661242-3 | Haemolytic Anaemia
Adverse event was reported on Feb 22, 2005 by a Male patient taking Leustatin (View Usage) (Dosage: Intravenous) was diagnosed with hairy cell leukaemia and. Location: , 45 years of age, weighting 169.8 lb, Patient had the following side effects: haemolytic anaemia. Patient was hospitalized.

4656121-1 | Ovarian Failure
on Apr 28, 2005 Female patient from , 22 years of age, was treated with Leustatin (View Usage). After Leustatin was administered, patient had the following side effects: ovarian failure. Leustatin dosage: .

4588350-X | Renal Failure Acute
on Feb 08, 2005 Female patient from , 68 years of age, was diagnosed with mantle cell lymphoma and was treated with Leustatin (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Leustatin dosage: .

4569151-5 | Ileus
Patient was taking Leustatin (View Usage). Patient had the following side effects: ileus on Jan 24, 2005 from Additional patient health information: Male patient , 51 years of age, . Leustatin dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), AMRUBICIN HYDROCHLORIDE (View Amrubicin Hydrochloride Review and Amrubicin Hydrochloride Label ). Patient was hospitalized.